Valuation: Perrigo Company plc

Market Cap 1.88B 1.64B 1.55B 1.41B 2.63B 180B 2.64B 18.45B 7.13B 91.45B 7.06B 6.9B 293B P/E 2026 *
1,354x
P/E 2027 * 11.3x
Enterprise Value 4.78B 4.17B 3.94B 3.58B 6.69B 458B 6.73B 46.97B 18.16B 233B 17.97B 17.57B 745B EV / Sales 2026 *
1.18x
EV / Sales 2027 * 1.14x
Free-Float
99.6%
Yield 2026 *
8.54%
Yield 2027 * 8.76%
1 day-0.89%
1 week-1.36%
Current month-8.44%
1 month+4.56%
3 months+31.94%
6 months+30.15%
Current year-3.70%
1 week 13.27
Extreme 13.27
14.28
1 month 12.8
Extreme 12.8
15
Current year 9.22
Extreme 9.225
15.38
1 year 9.22
Extreme 9.225
22.65
3 years 9.22
Extreme 9.225
34.6
5 years 9.22
Extreme 9.225
50.9
10 years 9.22
Extreme 9.225
99.14
Manager TitleAgeSince
Chief Executive Officer 63 06/06/2026
Director of Finance/CFO 51 15/05/2022
Chief Operating Officer - 22/06/2025
Director TitleAgeSince
Director/Board Member 75 31/10/2014
Director/Board Member 61 06/11/2016
Director/Board Member 70 05/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
11/09/26 Exercice

Director

5,192 0.0037%
11/09/26 Exercice

Director

3,133 0.0023%
09/09/26 Exercice

Executive/Senior Manager

18,186 0.0131%
Change 5-day change 1-year change 3-year change Capi.($)
-0.81%-1.36%-36.56%-60.47% 1.88B
+0.69%+2.06%+50.78%+100.62% 1,014B
+0.49%+0.57%+51.16%+64.86% 644B
-0.03%+2.87%+18.80%+70.41% 464B
-0.36%+4.54%+38.71%+40.03% 354B
+1.52%+3.46%+20.13%+26.08% 265B
+2.41%+5.70%+9.06%+15.85% 253B
+0.78%-0.81%+38.09%+44.16% 203B
+2.48%-2.43%-24.40%-57.05% 186B
+1.25%+3.25%+33.19%+97.72% 183B
Average +0.83%+0.30%+19.90%+34.22% 356.86B
Weighted average by Cap. +0.76%+1.41%+34.67%+61.01%

Financials

2026 *2027 *
Net sales 4.06B 3.54B 3.35B 3.04B 5.68B 389B 5.71B 39.86B 15.41B 198B 15.25B 14.91B 633B 4.09B 3.56B 3.37B 3.06B 5.72B 392B 5.75B 40.15B 15.53B 199B 15.36B 15.02B 637B
Net income -224M -195M -185M -168M -314M -21.46B -315M -2.2B -851M -10.91B -842M -823M -34.92B -56.95M -49.6M -46.95M -42.65M -79.68M -5.45B -80.08M -559M -216M -2.77B -214M -209M -8.87B
Net Debt 2.9B 2.53B 2.39B 2.18B 4.06B 278B 4.08B 28.52B 11.03B 141B 10.91B 10.67B 453B 2.78B 2.42B 2.29B 2.08B 3.9B 267B 3.91B 27.33B 10.57B 135B 10.46B 10.22B 434B
Logo Perrigo Company plc
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
8,100
Date Price Change Volume
17/09/26 US$13.40 -1.03% 697,689
16/09/26 US$13.54 -0.15% 2,105,783
15/09/26 US$13.56 -0.66% 2,281,530
14/09/26 US$13.65 -0.07% 1,925,222
11/09/26 US$13.66 +0.52% 1,828,693
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
13.54USD
Average target price
16.50USD
Spread / Average Target
+21.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PRGO Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!